Risk evaluation and early diagnosis can be determining factors in the way gynaecological cancers are dealt with, in the success rate of the treatment and in the quality of life of the patient.
The Gynaecology Unit is the most recent addition to the CCC and deals with the various types of gynaecological cancers, including cancers of the cervix, ovaries and endometrium.
Endometrial cancer is currently the most frequent malignant gynaecological cancer in women but has high treatment success rates, mainly since it is often diagnosed in its early stages. Ovarian cancer, despite having a low incidence, is one of the cancers with the highest rates of mortality in women. In both cases, genetic factors may be part of the equation and play an important role.
We know that the continuous development of a proactive risk evaluation and early diagnosis programme can be determining factors in the form of how gynaecological cancers are dealt with and the corresponding success rate of the treatment. It is precisely because we know this that the CCC’s Gynaecology Unit adopts the best and most recent protocols, both national and international, in this area of action.
The treatment of cancers associated to the female reproductive organs has in most cases implications for the future capacity of the patient to conceive, which is a particularly relevant factor for young women. The physical and emotional consequences which accompany this type of oncologic disease in the long-run are consequently an additional burden. To mitigate this suffering and guarantee that the best treatment plan is devised, each case is analysed by a Disease Management Team comprising professionals from numerous specialties, including medical oncologists, gynaecologists, surgeons, radiotherapists, radiologists, pathologists, geneticists, nuclear medicine specialists, nurses, psycho-oncologists, nutritionists and experts in palliative care.
Research is also a priority for all the members of the Gynaecology Unit. This research has the objective of contributing to the advancement of knowledge in this area and the development of new methods and techniques in order to continually improve treatment of gynaecological cancer sand patient life quality.
The members of this Unit are dedicated to the study and treatment of the following pathologies: cancer of the vulva, carcinoma of the vagina, cervical cancer, endometrial cancer, gestational trophoblastic neoplasia, uterine sarcomas, epithelial cancer of the fallopian tube, ovarian epithelial cancer and non-epithelial ovarian cancer.